Skip to main content
. 2021 Jan 15;48(8):2566–2572. doi: 10.1007/s00259-020-05177-z

Fig. 1.

Fig. 1

Camera images (with regions of interest; background regions not shown) of Patient 1 taken 1 day after administration of a 185 MBq [177Lu]Lu-DOTA-EB-TATE (red) and b 200 MBq [177Lu]Lu-DOTA-TOC (purple). c Measured total body retention and net counts per administered activity (cnts/MBq) in the regions of interest with bi-exponential fit functions. L1 and L2 denote tumour lesions